Literature DB >> 1537585

Properties of a low molecular weight complement component C6 found in human subjects with subtotal C6 deficiency.

A Orren1, R Würzner, P C Potter, B A Fernie, S Coetzee, B P Morgan, P J Lachmann.   

Abstract

A sensitive ELISA assay was used to quantitate serum complement component C6 concentrations. Levels in the range 0.3-3 micrograms/ml were measured in samples from eight individuals (four separate pedigrees) and two subjects with subtotal combined C6/C7 deficiency who have been reported previously. We defined C6 levels in this range as subtotal C6 deficiency (C6SD). In contrast, C6 deficiency with levels below 0.03 micrograms/ml was defined as C6Q0. C6Q0 has been found in 29 unrelated cases which have already been reported. Investigations of the properties of the C6 found in the C6SD subjects showed it to be haemolytically active and able to incorporate into the terminal complement complex. The protein had a relative molecular weight (Mr) of approximately 86% of normal C6 and this Mr was identical to that of the C6 of one combined deficient subject. The Mr of the C6 of the other combined deficient subject was previously estimated as 79% of the Mr of normal C6. Isoelectric focusing (IEF) analysis with band development by haemolytic overlay revealed that all C6SD samples produced an identical weak C6 band pattern anodal to normal C6A bands. The C7 IEF patterns of the two combined deficient subjects were identical, and the C6 IEF patterns of both were identical to those of the C6SD subjects. Thus the C6 of the combined deficient subjects is probably the same abnormal protein found in the C6SD individuals. None of the C6SD or combined deficient subjects have had meningococcal disease and it may be that low C6 levels afford some protection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537585      PMCID: PMC1384795     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies.

Authors:  R Würzner; M Schulze; L Happe; A Franzke; F A Bieber; M Oppermann; O Götze
Journal:  Complement Inflamm       Date:  1991

2.  Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement.

Authors:  P C Potter; C E Frasch; W J van der Sande; R C Cooper; Y Patel; A Orren
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals.

Authors:  R Würzner; A Orren; P Potter; B P Morgan; D Ponard; P Späth; M Brai; M Schulze; L Happe; O Götze
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

6.  Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency.

Authors:  B H Petersen; T J Lee; R Snyderman; G F Brooks
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

Review 7.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

8.  Inherited deficiency of the sixth component of complement: a silent or null gene.

Authors:  D Glass; D Raum; D Balavitch; E Kagan; A Rabson; P H Schur; C A Alper
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

9.  Arthritis and antinuclear antibodies (ANA) with inherited deficiency of the sixth component of complement (C6).

Authors:  E Reinitz; M Lawrence; B Diamond; H Keiser; C Alper
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

10.  Functional identification of serum complement components following electrophoresis in polyacrylamide gels containing sodium dodecyl sulphate.

Authors:  A Orren; W H Lerch; E B Dowdle
Journal:  J Immunol Methods       Date:  1983-04-15       Impact factor: 2.303

View more
  13 in total

Review 1.  Molecular mechanisms of complement component C6 deficiency; a hypervariable exon 6 region responsible for three of six reported defects.

Authors:  A Orren
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.

Authors:  Ann Orren; Ann M O'Hara; B Paul Morgan; Anthony P Moran; Reinhard Würzner
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

Review 3.  Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

4.  Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans.

Authors:  A Orren; E P Owen; H E Henderson; L van der Merwe; F Leisegang; C Stassen; P C Potter
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  Importance of the third thrombospondin repeat of C6 for terminal complement complex assembly.

Authors:  R Würzner; D Mewar; B A Fernie; M J Hobart; P J Lachmann
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

6.  Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.

Authors:  A M O'Hara; A P Moran; R Würzner; A Orren
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

Review 7.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

8.  C6 haplotypes: associations of a Dde I site polymorphism to complement deficiency genes and the Msp I restriction fragment length polymorphism (RFLP)

Authors:  B A Fernie; M J Hobart; G Delbridge; P C Potter; A Orren; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

9.  C7 M/N protein polymorphism typing applied to inherited deficiencies of human complement proteins C6 and C7.

Authors:  R Würzner; N Rance; P C Potter; M L Hendricks; P J Lachmann; A Orren
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

10.  Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6.

Authors:  R Würzner; M J Hobart; B A Fernie; D Mewar; P C Potter; A Orren; P J Lachmann
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.